To better understand the potential roles of glycogen metabolism in carcinogenesis and progression of GC, we performed consensus clustering analysis on 1150 GC patients from meta-cohort using 29 glycogen metabolism genes (excluding CALM2 and CALM3, which were not identified in the meta-cohort). This evidence concerns the gene CALM3 and gastric cancer.